191 related articles for article (PubMed ID: 26768745)
1. Alpinetin targets glioma stem cells by suppressing Notch pathway.
Wang J; Yan Z; Liu X; Che S; Wang C; Yao W
Tumour Biol; 2016 Jul; 37(7):9243-8. PubMed ID: 26768745
[TBL] [Abstract][Full Text] [Related]
2. Tanshinone IIA inhibits the growth, attenuates the stemness and induces the apoptosis of human glioma stem cells.
Yang L; Guo H; Dong L; Wang L; Liu C; Wang X
Oncol Rep; 2014 Sep; 32(3):1303-11. PubMed ID: 24970314
[TBL] [Abstract][Full Text] [Related]
3. A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells.
Kim RK; Kim MJ; Yoon CH; Lim EJ; Yoo KC; Lee GH; Kim YH; Kim H; Jin YB; Lee YJ; Cho CG; Oh YS; Gye MC; Suh Y; Lee SJ
Mol Pharmacol; 2012 Sep; 82(3):400-7. PubMed ID: 22648970
[TBL] [Abstract][Full Text] [Related]
4. Activation of estrogen receptor beta signaling reduces stemness of glioma stem cells.
Sareddy GR; Pratap UP; Venkata PP; Zhou M; Alejo S; Viswanadhapalli S; Tekmal RR; Brenner AJ; Vadlamudi RK
Stem Cells; 2021 May; 39(5):536-550. PubMed ID: 33470499
[TBL] [Abstract][Full Text] [Related]
5. Isoliquiritigenin inhibits the proliferation and induces the differentiation of human glioma stem cells.
Lin Y; Sun H; Dang Y; Li Z
Oncol Rep; 2018 Feb; 39(2):687-694. PubMed ID: 29251326
[TBL] [Abstract][Full Text] [Related]
6. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells.
Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM
Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773
[TBL] [Abstract][Full Text] [Related]
7. Telomestatin impairs glioma stem cell survival and growth through the disruption of telomeric G-quadruplex and inhibition of the proto-oncogene, c-Myb.
Miyazaki T; Pan Y; Joshi K; Purohit D; Hu B; Demir H; Mazumder S; Okabe S; Yamori T; Viapiano M; Shin-ya K; Seimiya H; Nakano I
Clin Cancer Res; 2012 Mar; 18(5):1268-80. PubMed ID: 22230766
[TBL] [Abstract][Full Text] [Related]
8. Targeting interleukin 6 signaling suppresses glioma stem cell survival and tumor growth.
Wang H; Lathia JD; Wu Q; Wang J; Li Z; Heddleston JM; Eyler CE; Elderbroom J; Gallagher J; Schuschu J; MacSwords J; Cao Y; McLendon RE; Wang XF; Hjelmeland AB; Rich JN
Stem Cells; 2009 Oct; 27(10):2393-404. PubMed ID: 19658188
[TBL] [Abstract][Full Text] [Related]
9. Suberoylanilide hydroxamic acid represses glioma stem-like cells.
Hsu CC; Chang WC; Hsu TI; Liu JJ; Yeh SH; Wang JY; Liou JP; Ko CY; Chang KY; Chuang JY
J Biomed Sci; 2016 Nov; 23(1):81. PubMed ID: 27863490
[TBL] [Abstract][Full Text] [Related]
10. Notch signaling contributes to the maintenance of both normal neural stem cells and patient-derived glioma stem cells.
Hu YY; Zheng MH; Cheng G; Li L; Liang L; Gao F; Wei YN; Fu LA; Han H
BMC Cancer; 2011 Feb; 11():82. PubMed ID: 21342503
[TBL] [Abstract][Full Text] [Related]
11. Glioma-derived cancer stem cells are hypersensitive to proteasomal inhibition.
Yoo YD; Lee DH; Cha-Molstad H; Kim H; Mun SR; Ji C; Park SH; Sung KS; Choi SA; Hwang J; Park DM; Kim SK; Park KJ; Kang SH; Oh SC; Ciechanover A; Lee YJ; Kim BY; Kwon YT
EMBO Rep; 2017 Jan; 18(1):150-168. PubMed ID: 27993939
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of ID1-BMPR2 Intrinsic Signaling Sensitizes Glioma Stem Cells to Differentiation Therapy.
Jin X; Jin X; Kim LJY; Dixit D; Jeon HY; Kim EJ; Kim JK; Lee SY; Yin J; Rich JN; Kim H
Clin Cancer Res; 2018 Jan; 24(2):383-394. PubMed ID: 29208670
[No Abstract] [Full Text] [Related]
13. Targeting glioma stem cells in vivo by a G-quadruplex-stabilizing synthetic macrocyclic hexaoxazole.
Nakamura T; Okabe S; Yoshida H; Iida K; Ma Y; Sasaki S; Yamori T; Shin-Ya K; Nakano I; Nagasawa K; Seimiya H
Sci Rep; 2017 Jun; 7(1):3605. PubMed ID: 28620243
[TBL] [Abstract][Full Text] [Related]
14. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth.
Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S
Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911
[TBL] [Abstract][Full Text] [Related]
15. Bufalin Induces Apoptosis and Improves the Sensitivity of Human Glioma Stem-Like Cells to Temozolamide.
Liu J; Zhang Y; Sun S; Zhang G; Jiang K; Sun P; Zhang Y; Yao B; Sui R; Chen Y; Guo X; Tang T; Shi J; Liang H; Piao H
Oncol Res; 2019 Mar; 27(4):475-486. PubMed ID: 29793559
[TBL] [Abstract][Full Text] [Related]
16. Fsk and IBMX inhibit proliferation and proapoptotic of glioma stem cells via activation of cAMP signaling pathway.
Lv P; Wang W; Cao Z; Zhao D; Zhao G; Li D; Qi L; Xu J
J Cell Biochem; 2019 Jan; 120(1):321-331. PubMed ID: 30171713
[TBL] [Abstract][Full Text] [Related]
17. A synthetic dl-nordihydroguaiaretic acid (Nordy), inhibits angiogenesis, invasion and proliferation of glioma stem cells within a zebrafish xenotransplantation model.
Yang X; Cui W; Yu S; Xu C; Chen G; Gu A; Li T; Cui Y; Zhang X; Bian X
PLoS One; 2014; 9(1):e85759. PubMed ID: 24454929
[TBL] [Abstract][Full Text] [Related]
18. Isocostunolide inhibited glioma stem cell by suppression proliferation and inducing caspase dependent apoptosis.
Dai Z; Li SR; Zhu PF; Liu L; Wang B; Liu YP; Luo XD; Zhao XD
Bioorg Med Chem Lett; 2017 Jul; 27(13):2863-2867. PubMed ID: 28487072
[TBL] [Abstract][Full Text] [Related]
19. Novel KDM1A inhibitors induce differentiation and apoptosis of glioma stem cells via unfolded protein response pathway.
Sareddy GR; Viswanadhapalli S; Surapaneni P; Suzuki T; Brenner A; Vadlamudi RK
Oncogene; 2017 Apr; 36(17):2423-2434. PubMed ID: 27893719
[TBL] [Abstract][Full Text] [Related]
20. miR-92a-3p Exerts Various Effects in Glioma and Glioma Stem-Like Cells Specifically Targeting CDH1/β-Catenin and Notch-1/Akt Signaling Pathways.
Song H; Zhang Y; Liu N; Zhao S; Kong Y; Yuan L
Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27801803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
